Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7918010 | 1.00 | TDP1 (0.68) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL7105787 | 0.93 | TDP1 (0.58) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL359304 | 0.89 | TDP1 (0.55) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL2580946 | 0.89 | TDP1 (0.55) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL2579133 | 0.89 | TDP1 (0.55) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL13227251 | 0.88 | TDP1 (0.64) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL7522431 | 0.88 | TDP1 (0.67) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL1920262 | 0.88 | TDP1 (0.67) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL1920258 | 0.88 | TDP1 (0.67) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL1920260 | 0.88 | TDP1 (0.67) | TDP1MEN1KMT2ALMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2412702-B1 | METHOD FOR PRODUCING CYCLOPROPANECARBOXYLIC ACID ESTER | SUMITOMO CHEMICAL CO (JP) | 2014-12-03 | — | — | EP | disclosed |
| US-8168816-B2 | Method for producing purified formylcyclopropane compound and intermediate of such formylcyclopropane compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20120029227-A1 | METHOD FOR PRODUCING CYCLOPROPANECARBOXYLIC ACID ESTER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-02 | — | — | US | disclosed |
| EP-2412702-A1 | METHOD FOR PRODUCING CYCLOPROPANECARBOXYLIC ACID ESTER | Sumitomo Chemical Company, Limited (JP) | 2012-02-01 | — | — | EP | disclosed |
| EP-1609776-B1 | PROCESS FOR PRODUCTION OF CARBONYL COMPOUNDS | SUMITOMO CHEMICAL CO (JP) | 2011-03-02 | — | — | EP | disclosed |
| US-20100305353-A1 | METHOD FOR PRODUCING PURIFIED FORMYLCYCLOPROPANE COMPOUND AND INTERMEDIATE OF SUCH FORMYLCYCLOPROPANE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-12-02 | — | — | US | disclosed |
| US-7700799-B2 | Method for producing (2-formyl-1-alkenyl) cyclopropane compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-20 | — | — | US | disclosed |
| US-20090137839-A1 | METHOD FOR PRODUCING (2-FORMYL-1-ALKENYL) CYCLOPROPANE COMPOUND | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2009-05-28 | — | — | US | disclosed |
| US-7498459-B2 | Method for producing (1-alkenyl)cyclopropane compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-03 | — | — | US | disclosed |
| EP-1463706-B1 | PROCESS FOR PRODUCTION OF 3,3-DIMETHYL-2-FORMYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVES | SUMITOMO CHEMICAL CO (JP) | 2008-02-27 | — | — | EP | disclosed |
| WO-2003059861-A1 | PROCESS FOR PRODUCTION OF 3,3-DIMETHYL-2-FORMYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-07-24 | — | — | WO | disclosed |
| EP-0963976-B1 | Oxyimino-substituted cyclopropanecarboxylate pesticides | SUMITOMO CHEMICAL CO (JP) | 2003-02-19 | — | — | EP | disclosed |
| EP-0939073-B1 | Ester of 2,2-dimethyl-cyclopropanecarboxylic acid and their use as pesticides | SUMITOMO CHEMICAL CO (JP) | 2002-12-04 | — | — | EP | disclosed |
| EP-1188735-A1 | Process for producing carbonyl or hydroxy compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-03-20 | — | — | EP | disclosed |
| US-20020025906-A1 | Process for producing carbonyl or hydroxy compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-02-28 | — | — | US | disclosed |
| EP-1120393-A1 | A process for producing 3,3-dimethyl-2-formylcyclopropane-carboxylic acid ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-08-01 | — | — | EP | disclosed |
| US-6225495-B1 | PESTICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-05-01 | — | — | US | disclosed |
| US-6034128-A | PESTICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-03-07 | — | — | US | disclosed |
| EP-0963976-A1 | Oxyimino-substituted cyclopropanecarboxylate pesticides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-15 | — | — | EP | disclosed |
| EP-0939073-A1 | Ester of 2,2-dimethyl-cyclopropanecarboxylic acid and their use as pesticides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029227-A1 | METHOD FOR PRODUCING CYCLOPROPANECARBOXYLIC ACID ESTER | PCCA, COASY, GRHPR | TDP1 4158/4885MEN1 3565/4885KMT2A 3385/4885 |
| US-20090137839-A1 | METHOD FOR PRODUCING (2-FORMYL-1-ALKENYL) CYCLOPROPANE COMPOUND | ACSL3, ACSL1, ARL1 | TDP1 4458/4885MEN1 2164/4885KMT2A 2422/4885 |
| US-20100305353-A1 | METHOD FOR PRODUCING PURIFIED FORMYLCYCLOPROPANE COMPOUND AND INTERMEDIATE OF SUCH FORMYLCYCLOPROPANE COMPOUND | FPR1, FPR2, DHPS | TDP1 3608/4885MEN1 1957/4885KMT2A 2717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.